Clinical Trials Directory

Trials / Completed

CompletedNCT05194267

Intensive tDCS for MDD: Feasibility Study

Intensive Transcranial Direct Current Stimulation in the Treatment of Major Depression: Feasibility Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This will be a prospective, open-label, single-arm study to determine the safety and feasibility of an intensive treatment of transcranial direct current stimulation (tDCS) for major depressive disorder (MDD). Participants will be age 18-65 with a diagnosis of unipolar MDD. Participants will receive an intensive treatment of tDCS over a 10-day treatment period and complete follow-up assessments at the end of treatment, 1, and 4 weeks post-treatment.

Detailed description

This will be a prospective, open-label, single-arm study to determine the safety and feasibility of an intensive treatment of transcranial direct current stimulation (tDCS) for major depressive disorder (MDD). Secondary objective is to gather preliminary data on the clinical effects of the protocol. After assessment and inclusion into the study, participants will receive up to 50 tDCS sessions over 10 days. Study procedures: Daily assessments: brief questions before and after each tDCS session to evaluate potential adverse events as well as a verbal rating scale for pain. Questionnaires : a battery of mood questionnaires will be completed to inform findings regarding clinical effects of the treatment. Cognitive measures: a short cognitive assessment will be completed to inform findings regarding cognitive safety of the treatment.

Conditions

Interventions

TypeNameDescription
DEVICEtranscranial direct current stimulation (tDCS)tDCS alters brain excitability using a weak electric field induced through two electrodes and could potentially improve symptoms of depression

Timeline

Start date
2022-02-02
Primary completion
2023-08-16
Completion
2023-08-16
First posted
2022-01-18
Last updated
2025-07-28
Results posted
2025-07-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05194267. Inclusion in this directory is not an endorsement.